Assumed biomarker status- and (sub-) trial-specific individual outcomes.

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/Assumed_biomarker_status-_and_sub-_trial-specific_individual_outcomes_/12809698 数据链接链接失效反馈

官方服务：

资源简介：

Assumed biomarker status- and (sub-) trial-specific individual outcomes.

创建时间：

2020-08-14

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

结直肠癌新辅助免疫治疗

精准医疗临床试验

Colorectal cancer (CRC) is the 2nd to 3rd most common malignant disease in developed countries, with over 1 million new cases and 500,000 deaths worldwide each year. The primary treatment for early st

NIAID Data Ecosystem70

Properties of adaptive clinical trial signature design in the presence of gene and gene-treatment interaction

精准医疗临床试验

生物标志物患者分层

Traditional phase III clinical trials are powered to detect an overall treatment effect. However, it has increasingly been shown that many treatments are effective only for a subset of a population. T

NIAID Data Ecosystem30

Genomic Analysis of Head and Neck Cancers

头颈癌基因组学

精准医疗临床试验

These aggregate studies focus on specimens from head and neck squamous cell carcinoma (HNSCC) patients who were treated with standard of care or window of opportunity clinical trial approaches. Specim

NIAID Data Ecosystem20

Supplementary Tables – Biomarker subset analysis of a Phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC

非小细胞肺癌治疗

生物标志物疗效分析

Supplementary Table 1. TRAEs occurring in ≥10% of patients. Supplementary Table 2. Subgroup analysis of TTSP and PFS in biomarker group.

DataCite Commons2024-02-14 更新40

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

转移性结直肠癌治疗

精准医疗临床试验

The purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given together for the treatment of colorectal cancer that: * is metastatic

NIAID Data Ecosystem30

Assumed biomarker status- and (sub-) trial-specific individual outcomes.

资源简介：

相关数据集